Peptides for anti-aging and longevity
Aging isn't one process — it's cellular housekeeping slowing down on many fronts at once: shorter telomeres, tired mitochondria, slower skin turnover. Peptides for anti-aging (epithalon, GHK-Cu, NAD, and others) each target one of those fronts.
These articles explain the biology in plain terms and are careful about the difference between findings in a lab dish and proven results in people. Everything offered here is prescription-only, reviewed by a licensed provider. None of them stops the clock, and the honest question is always which front matters for you.
44 articles on this topic
-
Epitalon News Update: October 2026
July brought favorable advisory votes and a new cancer-cell study. Here is what changed for epitalon, what the FDA’s current pages say, and what remains unproven in people.
-
MOTS-c Anti Aging: Human Benefits Remain Unproven
MOTS-c has not been shown to slow aging in people. Mouse findings and human blood measurements answer narrower questions about aging.
-
Epitalon Telomeres: What the Studies Actually Show
The claim comes from cells studied outside the body. Those findings haven't established a longer or healthier life for people taking epitalon.
-
Who Discovered NAD? The History Behind NAD+
Harden and Young found NAD's activity in yeast experiments, with a detailed paper in 1906. The vitamin, Nobel and longevity chapters came later.
-
Should I Take NAD+? A Provider's Decision Path
The answer starts with your goal and what is causing the tiredness. Oral supplement findings don't establish what NAD+ injections would do for you.
-
Is Epitalon FDA Approved? It Is Not
Epitalon is not FDA-approved. Its July 2026 committee recommendation concerned a compounding ingredient list, and FDA has not completed that rulemaking.
-
GHK-Cu News: October 2026 Update
New skin studies add useful detail about GHK-Cu, while human injection benefits remain unsettled. FDA's ingredient review is still pending.
-
NAD+ Myths: 7 Claims Checked Against the Evidence
Some swallowed supplements raise blood NAD+. That doesn't show injections make people younger or that a drip into a vein works better than a shot.
-
Who Discovered Epitalon? Vladimir Khavinson's Team
Vladimir Khavinson led the team behind epitalon. Its history runs from an animal pineal extract to a four-amino-acid peptide, with conflicting synthesis dates and important limits to the evidence.
-
Epitalon Side Effects: What Is and Isn't Known
Almost nobody has measured them. FDA's 2026 review found no clinical study of epitalon's safety in people, so the honest answer is mostly "unknown", and it helps to know exactly what that covers.
-
NAD+ News Update: September 2026
Supplements kept raising blood NAD+ this quarter without moving memory, fatigue or sleep scores, and NAD+'s regulatory status stayed where it was. Here is every dated change, June through September.
-
Epitalon Clinical Trials: What Was Actually Tested
The famous life-extension studies gave older adults a calf pineal extract, not synthetic epitalon. The synthetic peptide itself has been tested in people only a few times, briefly, by one research network.
-
GHK-Cu for Hair Growth: What the Evidence Shows
The copper peptide is all over hair-care feeds. The research behind it is mostly mice and cells, plus one famous follicle study that tested a different molecule.
-
MOTS-c News Update: September 2026
July's FDA advisory vote was the quarter's headline, but no rule has followed it. Here is what changed for MOTS-c from June to September, and what did not.
-
Who Discovered GHK-Cu? Loren Pickart, in 1973
Loren Pickart reported the peptide in human serum in 1973, its sequence followed in 1977 and its grip on copper in 1980. The history is well documented; the human evidence is much thinner.
-
Glutathione Injection Recall: Why People Got Sick
More than 25 people fell ill after IV glutathione, and three Texas pharmacies have recalled vials. FDA traced the problem to one ingredient lot: glutathione powder labeled for supplements, not for a vein.
-
NAD IV Death: What the Medical Examiner Found
The NAD IV death of a 27-year-old woman at a Bronx wellness business has been ruled a homicide. The reported cause was air in her IV line: a failure in how the drip was given, rather than a reaction to the drug.
-
MOTS-c Exercise Claims: What the Studies Show
MOTS-c is called an exercise mimetic because exercise raises it in people and administered MOTS-c changed running performance in mice. No published human trial shows that taking it improves a workout.
-
Who Discovered MOTS-c? The 2015 USC Discovery
Changhan Lee, Pinchas Cohen, and their colleagues reported MOTS-c in 2015. Its history runs from an overlooked genetic sequence to human observations and an ongoing question about treatment.
-
SS-31 Side Effects: What the Trials Found
SS-31 most often caused redness, itching, pain, or swelling where it was injected. Most reactions in trials were mild to moderate, but the label also warns about allergic reactions that can become serious.
Page 1 of 3 · 44 articles